Amendment: SEC Form SC 13G/A filed by enGene Holdings Inc.

11/14/24 5:48:15 PM ET

$ENGN

Biotechnology: Biological Products (No Diagnostic Substances)

Health Care

Get the next $ENGN alert in real time by email

SC 13G/A 1 tm2428137d8_sc13ga.htm SC 13G/A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G/A

Under the Securities Exchange Act of 1934

(Amendment No. 1)*

enGene Holdings Inc.

(Name of Issuer)

Common Shares, no par value per share

(Title of Class of Securities)

29286M105

(CUSIP Number)

September 30, 2024

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 29286M105

Page 2 of 14

1.	Names of Reporting Persons Venrock Healthcare Capital Partners III, L.P.
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) x (1) (b) ¨
3.	SEC Use Only
4.	Citizenship or Place of Organization Delaware

Number of

Beneficially

Owned by

Each

Reporting

Person With

Sole Voting Power

Shared Voting Power

3,565,841 (2)

Sole Dispositive Power

Shared Dispositive Power

3,565,841 (2)

9.	Aggregate Amount Beneficially Owned by Each Reporting Person 3,565,841 (2)
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
11.	Percent of Class Represented by Amount in Row (9) 8.1% (3)
12.	Type of Reporting Person (See Instructions) PN

(1)

Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management III, LLC, VHCP Management EG, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G/A.

(2)

Consists of (i) 832,381 shares held by Venrock Healthcare Capital Partners III, L.P.; (ii) 83,253 shares held by VHCP Co-Investment Holdings III, LLC; and (iii) 2,650,207 shares held by Venrock Healthcare Capital Partners EG, L.P.

(3)

This percentage is calculated based upon 44,215,577 Common shares issued and outstanding as of September 6, 2024 as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (the “SEC”) on September 10, 2024.

CUSIP No. 29286M105

Page 3 of 14

1.	Names of Reporting Persons VHCP Co-Investment Holdings III, LLC
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) x (1) (b) ¨
3.	SEC Use Only
4.	Citizenship or Place of Organization Delaware

Number of

Beneficially

Owned by

Each

Reporting

Person With

Sole Voting Power

Shared Voting Power

3,565,841 (2)

Sole Dispositive Power

Shared Dispositive Power

3,565,841 (2)

9.	Aggregate Amount Beneficially Owned by Each Reporting Person 3,565,841 (2)
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
11.	Percent of Class Represented by Amount in Row (9) 8.1% (3)
12.	Type of Reporting Person (See Instructions) OO

(1)

(2)

(3)

CUSIP No. 29286M105

Page 4 of 14

1.	Names of Reporting Persons Venrock Healthcare Capital Partners EG, L.P.
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) x (1) (b) ¨
3.	SEC Use Only
4.	Citizenship or Place of Organization Delaware

Number of

Beneficially

Owned by

Each

Reporting

Person With

Sole Voting Power

Shared Voting Power

3,565,841 (2)

Sole Dispositive Power

Shared Dispositive Power

3,565,841 (2)

9.	Aggregate Amount Beneficially Owned by Each Reporting Person 3,565,841 (2)
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
11.	Percent of Class Represented by Amount in Row (9) 8.1% (3)
12.	Type of Reporting Person (See Instructions) PN

(1)

(2)

(3)

CUSIP No. 29286M105

Page 5 of 14

1.	Names of Reporting Persons VHCP Management III, LLC
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) x (1) (b) ¨
3.	SEC Use Only
4.	Citizenship or Place of Organization Delaware

Number of

Beneficially

Owned by

Each

Reporting

Person With

Sole Voting Power

Shared Voting Power

3,565,841 (2)

Sole Dispositive Power

Shared Dispositive Power

3,565,841 (2)

9.	Aggregate Amount Beneficially Owned by Each Reporting Person 3,565,841 (2)
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
11.	Percent of Class Represented by Amount in Row (9) 8.1% (3)
12.	Type of Reporting Person (See Instructions) OO

(1)

(2)

(3)

CUSIP No. 29286M105

Page 6 of 14

1.	Names of Reporting Persons VHCP Management EG, LLC
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) x (1) (b) ¨
3.	SEC Use Only
4.	Citizenship or Place of Organization Delaware

Number of

Beneficially

Owned by

Each

Reporting

Person With

Sole Voting Power

Shared Voting Power

3,565,841 (2)

Sole Dispositive Power

Shared Dispositive Power

3,565,841 (2)

9.	Aggregate Amount Beneficially Owned by Each Reporting Person 3,565,841 (2)
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
11.	Percent of Class Represented by Amount in Row (9) 8.1% (3)
12.	Type of Reporting Person (See Instructions) OO

(1)

(2)

(3)

CUSIP No. 29286M105

Page 7 of 14

1.	Names of Reporting Persons Shah, Nimish
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) x (1) (b) ¨
3.	SEC Use Only
4.	Citizenship or Place of Organization United States

Number of

Beneficially

Owned by

Each

Reporting

Person With

Sole Voting Power

Shared Voting Power

3,565,841 (2)

Sole Dispositive Power

Shared Dispositive Power

3,565,841 (2)

9.	Aggregate Amount Beneficially Owned by Each Reporting Person 3,565,841 (2)
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
11.	Percent of Class Represented by Amount in Row (9) 8.1% (3)
12.	Type of Reporting Person (See Instructions) IN

(1)

(2)

(3)

CUSIP No. 29286M105

Page 8 of 14

1.	Names of Reporting Persons Koh, Bong
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) x (1) (b) ¨
3.	SEC Use Only
4.	Citizenship or Place of Organization United States

Number of

Beneficially

Owned by

Each

Reporting

Person With

Sole Voting Power

Shared Voting Power

3,565,841 (2)

Sole Dispositive Power

Shared Dispositive Power

3,565,841 (2)

9.	Aggregate Amount Beneficially Owned by Each Reporting Person 3,565,841 (2)
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
11.	Percent of Class Represented by Amount in Row (9) 8.1% (3)
12.	Type of Reporting Person (See Instructions) IN

(1)

(2)

(3)

CUSIP No. 29286M105

Page 9 of 14

Introductory Note: This Schedule 13G/A is filed on behalf of Venrock Healthcare Capital Partners III, L.P., a limited partnership organized under the laws of the State of Delaware (“VHCP III LP”), VHCP Co-Investment Holdings III, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Co-Investment III”), Venrock Healthcare Capital Partners EG, L.P., a limited partnership organized under the laws of the State of Delaware (“VHCP EG”), VHCP Management III, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Management III”), VHCP Management EG, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Management EG” and collectively with VHCP III LP, VHCP Co-Investment III, VHCP EG and VHCP Management III, the “Venrock Entities”), Nimish Shah (“Shah”) and Bong Koh (“Koh”) in respect of the Common Shares of enGene Holdings Inc.

Item 1.
	(a)	Name of Issuer enGene Holdings Inc.

	(b)	Address of Issuer’s Principal Executive Offices 4868 Rue Levy, Suite 220, Saint-Laurent, QC, Canada H4R 2P1

Item 2.
	(a)	Name of Person Filing Venrock Healthcare Capital Partners III, L.P. VHCP Co-Investment Holdings III, LLC Venrock Healthcare Capital Partners EG, L.P. VHCP Management III, LLC VHCP Management EG, LLC Nimish Shah Bong Koh

	(b)	Address of Principal Business Office or, if none, Residence

	New York Office:	Palo Alto Office:

	7 Bryant Park	3340 Hillview Avenue
	23rd Floor	Palo Alto, CA 94304
	New York, NY 10018

	(c)	Citizenship All of the Venrock Entities were organized in Delaware. The individuals are both United States citizens.

	(d)	Title of Class of Securities Common Shares, no par value per share

	(e)	CUSIP Number 29286M105

CUSIP No. 29286M105

Page 10 of 14

Item 3.	If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
	Not applicable


Item 4.	Ownership
	(a)	Amount beneficially owned as of September 30, 2024:

Venrock Healthcare Capital Partners III, L.P.	3,565,841	(1)
VHCP Co-Investment Holdings III, LLC	3,565,841	(1)
Venrock Healthcare Capital Partners EG, L.P.	3,565,841	(1)
VHCP Management III, LLC	3,565,841	(1)
VHCP Management EG, LLC	3,565,841	(1)
Nimish Shah	3,565,841	(1)
Bong Koh	3,565,841	(1)

(b)

Percent of class as of September 30, 2024:

Venrock Healthcare Capital Partners III, L.P.	8.1	%(2)
VHCP Co-Investment Holdings III, LLC	8.1	%(2)
Venrock Healthcare Capital Partners EG, L.P.	8.1	%(2)
VHCP Management III, LLC	8.1	%(2)
VHCP Management EG, LLC	8.1	%(2)
Nimish Shah	8.1	%(2)
Bong Koh	8.1	%(2)

	(c)	Number of shares as to which the person has, as of September 30, 2024:
		(i)	Sole power to vote or to direct the vote:

	Venrock Healthcare Capital Partners III, L.P.			0
	VHCP Co-Investment Holdings III, LLC			0
	Venrock Healthcare Capital Partners EG, L.P.			0
	VHCP Management III, LLC			0
	VHCP Management EG, LLC			0
	Nimish Shah			0
	Bong Koh			0

CUSIP No. 29286M105

Page 11 of 14

(ii)

Shared power to vote or to direct the vote:

Venrock Healthcare Capital Partners III, L.P.	3,565,841	(1)
VHCP Co-Investment Holdings III, LLC	3,565,841	(1)
Venrock Healthcare Capital Partners EG, L.P.	3,565,841	(1)
VHCP Management III, LLC	3,565,841	(1)
VHCP Management EG, LLC	3,565,841	(1)
Nimish Shah	3,565,841	(1)
Bong Koh	3,565,841	(1)

(iii)

Sole power to dispose or to direct the disposition of:

	Venrock Healthcare Capital Partners III, L.P.			0
	VHCP Co-Investment Holdings III, LLC			0
	Venrock Healthcare Capital Partners EG, L.P.			0
	VHCP Management III, LLC			0
	VHCP Management EG, LLC			0
	Nimish Shah			0
	Bong Koh			0

(iv)

Shared power to dispose or to direct the disposition of:

Venrock Healthcare Capital Partners III, L.P.	3,565,841	(1)
VHCP Co-Investment Holdings III, LLC	3,565,841	(1)
Venrock Healthcare Capital Partners EG, L.P.	3,565,841	(1)
VHCP Management III, LLC	3,565,841	(1)
VHCP Management EG, LLC	3,565,841	(1)
Nimish Shah	3,565,841	(1)
Bong Koh	3,565,841	(1)

(1)

VHCP Management III, LLC is the general partner of Venrock Healthcare Capital Partners III, L.P. and the manager of VHCP Co-Investment Holdings III, LLC. VHCP Management EG, LLC is the general partner of Venrock Healthcare Capital Partners EG, L.P. Messrs. Shah and Koh are the voting members of VHCP Management III, LLC and VHCP Management EG, LLC.

(2)

Item 5.	Ownership of Five Percent or Less of a Class
	If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ¨

CUSIP No. 29286M105

Page 12 of 14

Item 6.	Ownership of More than Five Percent on Behalf of Another Person
	Not applicable

Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person
	Not applicable

Item 8.	Identification and Classification of Members of the Group
	Not applicable

Item 9.	Notice of Dissolution of Group
	Not applicable

Item 10.	Certification
	By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having such purpose or effect.

CUSIP No. 29286M105

Page 13 of 14

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: November 14, 2024

Venrock Healthcare Capital Partners III, L.P.		Venrock Healthcare Capital Partners EG, L.P.

By:	VHCP Management III, LLC	By:	VHCP Management EG, LLC
Its:	General Partner	Its:	General Partner

By:	/s/ Sherman G. Souther	By:	/s/ Sherman G. Souther
	Name: Sherman G. Souther		Name: Sherman G. Souther
	Its: Authorized Signatory		Its: Authorized Signatory

VHCP Co-Investment Holdings III, LLC

By:	VHCP Management III, LLC
Its:	Manager

By:	/s/ Sherman G. Souther
	Name: Sherman G. Souther
	Its: Authorized Signatory

VHCP Management III, LLC		VHCP Management EG, LLC

By:	/s/ Sherman G. Souther	By:	/s/ Sherman G. Souther
	Name: Sherman G. Souther		Name: Sherman G. Souther
	Its: Authorized Signatory		Its: Authorized Signatory

Nimish Shah

/s/ Sherman G. Souther
Sherman G. Souther, Attorney-in-fact

Bong Koh

/s/ Sherman G. Souther
Sherman G. Souther, Attorney-in-fact

CUSIP No. 29286M105

Page 14 of 14

EXHIBITS

Joint Filing Agreement (incorporated by reference to Exhibit A to Schedule 13G filed on February 26, 2024)

Power of Attorney for Nimish Shah (incorporated by reference to Exhibit B to Schedule 13G filed February 26, 2024)

Power of Attorney for Bong Koh (incorporated by reference to Exhibit C to Schedule 13G filed on February 26, 2024)

Get the next $ENGN alert in real time by email

Date	Price Target	Rating	Analyst
2/18/2025	$26.00	Overweight	Piper Sandler
2/14/2025	$34.00 → $7.00	Buy → Neutral	UBS
12/23/2024	$25.00	Buy	H.C. Wainwright
11/27/2024	$23.00	Outperform	Raymond James
11/18/2024	$18.00	Mkt Outperform	JMP Securities
8/28/2024	$30.00	Outperform	Oppenheimer
4/22/2024	$30.00	Overweight	Wells Fargo
4/15/2024	$34.00	Buy	Guggenheim

Amendment: SEC Form SC 13G/A filed by enGene Holdings Inc.

Chat with this insight

Recent Analyst Ratings for $ENGN

$ENGN Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Large owner Forbion Growth Opportunities Fund I Cooperatief U.A. bought $4,999,993 worth of shares (561,797 units at $8.90) (SEC Form 4)

Large owner Forbion Growth Opportunities Fund I Cooperatief U.A. bought $3,012,674 worth of shares (470,633 units at $6.40) (SEC Form 4)

Chief Executive Officer Cooper Ronald Harold Wilfred bought $57,000 worth of shares (10,000 units at $5.70) (SEC Form 4)

$ENGN Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

SEC Form 4 filed by Chief Medical Officer Pruthi Raj Som

SEC Form 4 filed by Chief Strategy & Ops. Ofc Nichols Alexander Julian

SEC Form 4 filed by Chief Legal Ofc. and Corp Secy Giguere Lee

$ENGN Leadership Updates

Live Leadership Updates

enGene Appoints Joan Connolly as Chief Technology Officer and Anthony Cheung, Ph.D., as Chief Scientific Officer

enGene Announces Appointment of Ron Cooper as Chief Executive Officer

enGene Announces the Election of Paul Hastings and Wouter Joustra to its Board of Directors

$ENGN Press Releases

Fastest customizable press release news feed in the world

enGene to Participate in Upcoming Investor Conferences

enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

enGene to Present at the Stifel 2025 Virtual Targeted Oncology Forum

$ENGN Large Ownership Changes

This live feed shows all institutional transactions in real time.